Jennifer Erickson Takes the Helm as CEO of Sonora Quest Laboratories

Transition of Leadership at Sonora Quest Laboratories

Sonora Quest Laboratories has recently made headlines with the announcement of Jennifer Erickson as the new Chief Executive Officer-Elect, succeeding the long-standing CEO David Dexter. This change marks a significant milestone for the company, which has been under Dexter's leadership for over 26 years. The appointment highlights Sonora Quest's ongoing commitment to excellence and innovation in the field of diagnostic testing in Arizona.

A Legacy of Leadership

David Dexter has been a pivotal figure at Sonora Quest since he took on the role of president and CEO in 1999. Under his guidance, Sonora Quest has flourished as the leading provider of clinical laboratory testing in Arizona, performing more than 100 million diagnostic tests annually. Dexter’s leadership has seen the implementation of groundbreaking platforms, including the direct-access testing service, My Lab ReQuest™, initiated in 2015, and the strategic launch of Operation Catapult to enhance COVID-19 testing capabilities during the pandemic.

Reflecting on his tenure, Dexter expressed a mix of gratitude and nostalgia. He noted that the most cherished memories of his career are not just the achievements and specific milestones but the relationships he has built and the resilience demonstrated through challenges. He emphasized the importance of creativity and innovation in driving the company forward and supporting public health initiatives across Arizona.

Jennifer Erickson's Vision

With over 20 years of experience in healthcare and consumer services, Jennifer Erickson is poised to carry forward the legacy left by Dexter. Previously, she has held prestigious roles, including Chief Financial Officer and Chief Operating Officer at Clin-Path Associates/Pathology Specialists of Arizona. Notably, she also served as Sonora Quest's Chief Financial Officer from 1999 to 2004, providing her with a deep understanding of the company’s governance and operational frameworks.

Erickson's appointment comes at a crucial time as the company seeks to expand its patient-centered diagnostic services and strengthen its partnerships. Her focus will be on fostering a culture of collaboration and accountability, key components that have contributed to the company’s success thus far.

Reflecting on her new role, Erickson stated, "Returning to lead the company that gave me such a strong foundation in health care leadership is both an honor and a tremendous responsibility. This full-circle moment underscores the impact of strong mentorship and effective leadership. I am eager to build on a legacy defined by forward-thinking and meaningful relationships."

The Future of Sonora Quest

As Dexter prepares to officially retire on March 31, he will collaborate closely with Erickson starting February 2 to ensure a seamless transition of leadership. Dexter's confidence in Erickson’s capabilities is evident in his comments, where he described her as an excellent fit to succeed him, ensuring the spirit of strong leadership continues at Sonora Quest.

Under Erickson's stewardship, Sonora Quest Laboratories is set to embark on a new chapter filled with opportunity and continued commitment to healthcare innovation and community partnerships.

For further information about Sonora Quest Laboratories and its array of diagnostic services, visit www.SonoraQuest.com.